Does bovine lactoferrin (bLF) improve morbidity-free survival and severe retinopathy in very low birthweight infants? The Lactoferrin Infant Feeding Trial (LIFT).

牛乳铁蛋白 (bLF) 能否改善极低出生体重婴儿的无发病率生存率和严重视网膜病变？

• 批准号: 355867
• 负责人: Asztalos Elizabeth V
• 金额: $ 86.38万
• 依托单位: Sunnybrook Research Institute (Toronto, Ontario)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2016
• 资助国家: 加拿大
• 起止时间: 2016-10-01 至 2021-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=355867&lang=en
• 关键词: Bovine Lactoferrin; Neonatal Morbidities; Neonatal Survival; Preterm Infants

Lactoferrin is a whey protein found in breast milk. Bovine lactofferin is very similar to human lactoferrin. Recent studies have suggested that giving bovine lactoferrin to preterm infants with a birthweight < 1500 grams on a daily basis for a minimum of

乳铁蛋白是一种乳清蛋白，存在于母乳中。牛乳铁蛋白与人乳铁蛋白非常相似。最近的研究表明，对于出生体重< 1500克的早产儿，每天至少给予牛乳铁蛋白